Peresolimab is a humanized IgG1-κ antibody targeting to PD-1. Peresolimab potentially stimulates psiological immune inhibitory pathways to restore immune homeostasis.
References:
[1]. Tuttle J, et al. Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply. N Engl J Med. 2023 Jul 27;389(4):378-379.
[2]. Peresolimab. IMGT/mAb-DB.
















